₹704.20-3.30 (-0.47%)
04:01 PM, 10-Nov-2025₹704.95-2.65 (-0.37%)
03:46 PM, 10-Nov-2025BSE : 543064
NSE : COHANCE
Sector : Health care
ISIN Code : INE03QK01018
Last Updated: 10-Nov-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 26,943 |
Traded Value (₹ Cr) | 25.60 |
Volume (Shares) | 3,63,495 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,359.00 |
52-Week High Date | 02-Dec-2024 |
52-Week Low (₹) | 700.15 |
52-Week Low Date | 10-Nov-2025 |
All Time High (₹) | 1,359.00 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 87.05 |
All Time Low Date | 24-Mar-2020 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 26,971 |
| EPS - TTM (₹) [C] | 8.60 |
| P/E Ratio (X) [C] | 81.97 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 44.68 |
| P/B Ratio (₹) [C] | 15.78 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Flexi Cap Fund - (IDCW) | 301.36 | 40,00,000 | 0.33 |
| HDFC Flexi Cap Fund - (G) | 301.36 | 40,00,000 | 0.33 |
| HDFC Flexi Cap Fund - Direct (IDCW) | 301.36 | 40,00,000 | 0.33 |
| HDFC Flexi Cap Fund - Direct (G) | 301.36 | 40,00,000 | 0.33 |
| Invesco India Contra Fund (G) | 250.43 | 33,23,946 | 1.24 |
| Invesco India Contra Fund - Direct (G) | 250.43 | 33,23,946 | 1.24 |
| DSP ELSS Tax Saver Fund (G) | 247.51 | 32,85,254 | 1.44 |
| DSP ELSS Tax Saver Fund (IDCW) | 247.51 | 32,85,254 | 1.44 |
| DSP ELSS Tax Saver Fund - Direct (IDCW) | 247.51 | 32,85,254 | 1.44 |
| DSP ELSS Tax Saver Fund - Direct (G) | 247.51 | 32,85,254 | 1.44 |
Load more
| Today's Low/High (₹) | 702.20 715.00 |
| Week Low/High (₹) | 702.20 761.00 |
| Month Low/High (₹) | 702.20 918.00 |
| Year Low/High (₹) | 702.20 1,360.00 |
| All time Low/High (₹) | 87.05 1,360.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -5.13% | -5.10% | -0.53% | -0.73% |
| 1 Month | -22.09% | -22.08% | 1.25% | 1.14% |
| 3 Month | -24.33% | -24.45% | 4.61% | 4.97% |
| 6 Month | -34.65% | -34.59% | 5.14% | 6.52% |
| 1 Year | -45.14% | -45.26% | 5.09% | 5.91% |
| 3 Year | 60.98% | 61.11% | 37.82% | 41.86% |
Chairman & Exec. Director : Vivek Sharma
Non-Exec & Non-Independent Dir : Vinod Padikkal
Independent Non Exe. Director : K G Ananthakrishnan
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : Vinod Rao
Independent Non Exe. Director : U B Pravin Rao
Independent Non Exe. Director : Jaishankar Krishnan
Non Executive Director : Pankaj Patwari
Non Executive Director : Shweta Jalan
CS / Compliance Officer / Legal Head : KUNDAN KUMAR JHA
Whole Time Director & Chief Financial Officer : Himanshu Agarwal
Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311
Email:khrao@suvenpharm.com
1. What's the Cohance Lifesciences Ltd share price today?
Cohance Lifesciences Ltd share price was Rs 704.20 at 04:01 PM IST on 10th Nov 2025. Cohance Lifesciences Ltd share price was down by 0.47% from the previous closing price of Rs 707.50. Cohance Lifesciences Ltd share price trend:
2. How can I quickly analyse the performance of the Cohance Lifesciences Ltd stock?
The performance of the Cohance Lifesciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd has a market capitalisation of Rs 26,943 crore.
4. What is Cohance Lifesciences Ltd's 52-week high/low share price?
The Cohance Lifesciences Ltd’s 52-week high share price is Rs 1,359.00 and 52-week low share price is Rs 700.15.
5. Is the Cohance Lifesciences Ltd profitable?
On a consolidated basis, Cohance Lifesciences Ltd reported a profit of Rs 46.40 crore on a total income of Rs 563.48 crore for the quarter ended 2025.
6. Which are Cohance Lifesciences Ltd’s peers in the Health care sector?
Cohance Lifesciences Ltd’s top 5 peers in the Health care sector are Gland Pharma, J B Chemicals &, Emcure Pharma, Cohance Life, Piramal Pharma, Pfizer, Neuland Labs..
7. Who owns how much in Cohance Lifesciences Ltd?
Key changes to the Cohance Lifesciences Ltd shareholding are as follows: